IHS Chemical Week

Regions :: South America :: Brazil

Sanofi-Aventis to Buy Firms in Brazil and U.S.

8:49 AM MDT | April 24, 2009 | DEEPTI RAMESH

Sanofi-Aventis (Paris) says it has agreed to acquire Medley (Campinas, Brazil), Brazil’s largest generics drugmaker and third-largest pharmaceutical company, for about €500 million ($650 million). Separately, Sanofi-Aventis has inked a deal to acquire BiPar Sciences (Brisbane, CA), a privately held biopharma company, for up to $500 million, depending on the achievement of certain milestone payments. Both transactions are expected to close this quarter. The Medley deal will enable Sanofi-Aventis to become the leading player in generics in Brazil and...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa